Cumberland Pharmaceuticals logo

Cumberland Pharmaceuticals (CPIX) Q1 2025 Earnings

CPIX·Reported May 6, 2025·After market close

Cumberland Pharmaceuticals reported Q1 2025 revenue of $11.7M (+37.8% YoY). Diluted EPS came in at $0.16.

Revenue
$11.7M
Diluted EPS
$0.16
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2025

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Cumberland Pharmaceuticals's Q1 2025 earnings report.

Cumberland Pharmaceuticals (CPIX) reported Q1 2025 earnings on May 6, 2025 after market close.

Cumberland Pharmaceuticals reported revenue of $11.7M and diluted EPS of $0.16 for Q1 2025.

Compared to the same quarter a year prior, revenue grew 37.8% from $8.5M a year earlier.

You can read the 10-Q periodic report (0001628280-25-024342) directly on SEC EDGAR. The filing index links above go to sec.gov.